IIT-Madras, IRFC Partner to Establish India’s First SCOT Research Lab
On November 18, 2025, the Indian Institute of Technology Madras (IIT Madras) announced its partnership with the Indian Railways Finance Corporation (IRFC) to establish India’s first ‘Single Cell Omics Translational (SCOT) Research Laboratory’. This groundbreaking initiative aims to advance the precision healthcare ecosystem in India by bridging the gap between engineering and medicine.
Overview of the SCOT Research Laboratory
The newly inaugurated SCOT Lab, located within the Department of Medical Sciences and Technology (DMST) at IIT Madras, is equipped with state-of-the-art instrumentation. The facility is designed to facilitate:
- Early diagnosis of diseases
- Disease prognosis
- Biomarker discovery
- Drug screening across various diseases
These diseases include cancer, cardiovascular issues, infectious diseases, inflammatory conditions, metabolic disorders, and other non-communicable diseases.
Funding and Support
The establishment of the SCOT Lab is made possible through a Corporate Social Responsibility (CSR) grant of ₹10.83 crore provided by IRFC. This funding is crucial for accelerating research in single-cell biology, drug discovery, biomarker identification, and translational healthcare innovation.
Inauguration Ceremony
The launch of the SCOT Research Laboratory was attended by several dignitaries, including:
- Prof. V. Kamakoti, Director, IIT Madras
- Ms. Usha Venugopal, Member (Finance), Ministry of Railways
- Mr. Manoj Kumar Dubey, Chairman and Managing Director, IRFC
- Prof. Ashwin Mahalingam, Dean (Alumni and Corporate Relations), IIT Madras
- Prof. Boby George, Head, DMST, IIT Madras
- Prof. Krishna Kumar, DMST, IIT Madras
- Prof. Anubama Rajan, Project Coordinator, DMST, IIT Madras
Significance of the SCOT Lab
Prof. V. Kamakoti emphasized the importance of such facilities in driving the ‘Make in India’ initiative within critical fields like healthcare. He stated, “Our collaboration with IRFC marks an important milestone in accelerating India’s journey in drug discovery and precision medicine.” The SCOT Research Laboratory is expected to significantly enhance India’s capabilities in:
- Early diagnostics
- Targeted therapeutics
- Next-generation healthcare innovation
Future Prospects
Ms. Usha Venugopal expressed optimism regarding the potential impact of the SCOT Research Lab on medical research capabilities in India. She stated, “The support extended through IRFC’s CSR funding will aid studies that have the potential to improve early diagnosis and develop better therapies.” This collaboration exemplifies how institutions can work together to achieve larger national goals.
Transformative Potential
The partnership between IIT Madras and IRFC is a transformative step toward decoding diseases at an unprecedented cellular level. This initiative paves the way for personalized treatment strategies and next-generation therapeutics. Prof. Anubama Rajan highlighted the need for research platforms that can connect molecular insights directly to clinical impact, stating, “With the SCOT Research Laboratory established in partnership with IRFC, we now have the capability to study diseases at single-cell resolution, accelerate drug discovery, and develop early-detection and precision-medicine strategies tailored to our patients.”
Training and Development
The SCOT Research Laboratory will also serve as a national training hub, bringing together clinicians, scientists, and engineers to build the next generation of India’s translational research ecosystem. This facility enhances India’s ability to drive drug discovery, early diagnostics, and precision healthcare.
Conclusion
The establishment of the SCOT Research Laboratory at IIT Madras represents a significant advancement in India’s healthcare research capabilities. By leveraging innovative technologies and fostering collaboration between engineering and medical sciences, this initiative is poised to make a lasting impact on public health in India.
Note: This article is based on information available as of October 2023 and aims to provide an overview of the SCOT Research Laboratory initiative.
